ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 67 filers reported holding ALBIREO PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $957,000 | -13.7% | 29,415 | -2.6% | 0.00% | -100.0% |
| Q2 2021 | $1,109,000 | -21.7% | 30,200 | -28.3% | 0.00% | 0.0% |
| Q1 2021 | $1,417,000 | -39.3% | 42,097 | -32.9% | 0.00% | -50.0% |
| Q4 2020 | $2,336,000 | +10518.2% | 62,757 | +10104.4% | 0.00% | – |
| Q3 2020 | $22,000 | -97.7% | 615 | -98.4% | 0.00% | -100.0% |
| Q2 2020 | $948,000 | +73.0% | 37,434 | +7.0% | 0.00% | 0.0% |
| Q1 2020 | $548,000 | -36.6% | 35,000 | +3.0% | 0.00% | 0.0% |
| Q4 2019 | $864,000 | +3500.0% | 33,995 | +2704.9% | 0.00% | – |
| Q3 2019 | $24,000 | -36.8% | 1,212 | +3.1% | 0.00% | – |
| Q2 2019 | $38,000 | -74.3% | 1,175 | -74.4% | 0.00% | – |
| Q1 2019 | $148,000 | +35.8% | 4,588 | +2.9% | 0.00% | – |
| Q4 2018 | $109,000 | -24.3% | 4,457 | +1.5% | 0.00% | – |
| Q3 2018 | $144,000 | -7.7% | 4,393 | -0.0% | 0.00% | – |
| Q2 2018 | $156,000 | +9.9% | 4,395 | +1.5% | 0.00% | – |
| Q1 2018 | $142,000 | – | 4,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 198,800 | $5,266,000 | 2.26% |
| Perceptive Advisors | 1,960,139 | $51,924,000 | 0.84% |
| Chicago Capital, LLC | 502,212 | $13,304,000 | 0.77% |
| Birchview Capital, LP | 48,000 | $1,272,000 | 0.77% |
| Artal Group S.A. | 500,360 | $13,255,000 | 0.37% |
| HEARTLAND ADVISORS INC | 150,000 | $3,974,000 | 0.35% |
| Eversept Partners, LP | 78,029 | $2,066,988 | 0.28% |
| ArrowMark Colorado Holdings LLC | 956,990 | $25,351,000 | 0.26% |
| PA Capital LLC | 12,987 | $344,000 | 0.25% |
| Ikarian Capital, LLC | 100,500 | $2,662,000 | 0.21% |